Precision Biosciences Inc (DTIL) insider trading
Every open-market stock purchase and sale by Precision Biosciences Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $466K over the last 12 months (11 sales).
- Last insider buy: Geno J Germano (Director), $14.2K, 10 months ago.
Last 12 months: insiders bought $33.7K (3 buys) and sold $466K (11 sales). Last close $6.50 on Jun 4, 2026.
Recent DTIL insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 3, 2026 | Stanley Frankel (Director) | Bought (not open market) | — |
| Jun 3, 2026 | Geno J Germano (Director) | Bought (not open market) | — |
| Jun 3, 2026 | Kevin Buehler (Director) | Bought (not open market) | — |
| Jun 3, 2026 | Shari Lisa Pire (Director) | Bought (not open market) | — |
| Jun 3, 2026 | Melinda Brown (Director) | Bought (not open market) | — |
| Jun 1, 2026 | Dario Scimeca (General Counsel) | Bought (not open market) | — |
| Jun 1, 2026 | Michael Amoroso (CEO) | Bought (not open market) | — |
| Jun 1, 2026 | John Alexander Kelly (CFO) | Bought (not open market) | — |
| Jun 1, 2026 | J. Jefferson Smith (C-suite exec) | Bought (not open market) | — |
| May 20, 2026 | Melinda Brown (Director) | Bought (not open market) | — |
| May 20, 2026 | Shari Lisa Pire (Director) | Bought (not open market) | — |
| May 20, 2026 | Kevin Buehler (Director) | Bought (not open market) | — |
| May 20, 2026 | Stanley Frankel (Director) | Bought (not open market) | — |
| May 20, 2026 | Geno J Germano (Director) | Bought (not open market) | — |
| Feb 18, 2026 | Michael Amoroso (CEO) | Sold | $78.9K |
| Feb 18, 2026 | John Alexander Kelly (CFO) | Sold | $31.3K |
| Feb 18, 2026 | J. Jefferson Smith (C-suite exec) | Sold | $18.9K |
| Feb 18, 2026 | Dario Scimeca (General Counsel) | Sold | $18.9K |
| Feb 17, 2026 | J. Jefferson Smith (C-suite exec) | Bought (not open market) | — |
| Feb 17, 2026 | John Alexander Kelly (CFO) | Bought (not open market) | — |
| Feb 17, 2026 | Michael Amoroso (CEO) | Bought (not open market) | — |
| Feb 17, 2026 | Dario Scimeca (General Counsel) | Bought (not open market) | — |
| Jan 22, 2026 | Michael Amoroso (CEO) | Sold | $145K |
| Jan 21, 2026 | John Alexander Kelly (CFO) | Sold | $61.3K |
| Jan 21, 2026 | J. Jefferson Smith (C-suite exec) | Sold | $41.1K |
Who's trading DTIL
- Melinda Brown, Insider: bought $6.9K (1 buy), last Jun 3, 2026
- Shari Lisa Pire, Insider: other filings, last Jun 3, 2026
- Kevin Buehler, Insider: other filings, last Jun 3, 2026
- Stanley Frankel, Director: bought $12.7K (1 buy), last Jun 3, 2026
- Geno J Germano, Insider: bought $14.2K (1 buy), last Jun 3, 2026
- Michael Amoroso, CEO: sold $246K (3 sales), last Jun 1, 2026
- John Alexander Kelly, CFO: sold $101K (3 sales), last Jun 1, 2026
- J. Jefferson Smith, C-suite exec: sold $60K (2 sales), last Jun 1, 2026
- Dario Scimeca, General Counsel: sold $58.9K (3 sales), last Jun 1, 2026
Get free alerts when an insider at Precision Biosciences Inc files a new trade →